{"protocolSection":{"identificationModule":{"nctId":"NCT04971564","orgStudyIdInfo":{"id":"FDE_2021_19"},"organization":{"fullName":"Fondation Ophtalmologique Adolphe de Rothschild","class":"NETWORK"},"briefTitle":"Thrombo-inflammation Biomarkers Trial in Acute Cerebral Hypoxia","officialTitle":"Thrombo-inflammation Biomarkers Trial in Acute Cerebral Hypoxia. A Case-control Trial Nested in a Cohort","acronym":"RADICAL"},"statusModule":{"statusVerifiedDate":"2023-11","overallStatus":"NOT_YET_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2024-01-15","type":"ESTIMATED"},"primaryCompletionDateStruct":{"date":"2025-08-15","type":"ESTIMATED"},"completionDateStruct":{"date":"2025-08-15","type":"ESTIMATED"},"studyFirstSubmitDate":"2021-07-12","studyFirstSubmitQcDate":"2021-07-12","studyFirstPostDateStruct":{"date":"2021-07-21","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-11-20","lastUpdatePostDateStruct":{"date":"2023-11-21","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Fondation Ophtalmologique Adolphe de Rothschild","class":"NETWORK"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The goal of this trial is to study, in three well-defined clinical situations responsible for cerebral hypoxia, the concentrations of biomarkers of thrombo-inflammation compared to a population of patients without cerebral hypoxia, and to study in patients with cerebral hypoxia the association between these concentrations and the clinical evolution."},"conditionsModule":{"conditions":["Cerebral Hypoxia","Ischemic Stroke"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"CASE_CONTROL","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":200,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Case","description":"Patients with cerebral hypoxia victims of ischaemic stroke, acute parenchymal haemorrhage or subarachnoid haemorrhage","interventionNames":["Other: Blood sampling"]},{"label":"Control","description":"Patients without cerebral hypoxia","interventionNames":["Other: Blood sampling"]}],"interventions":[{"type":"OTHER","name":"Blood sampling","description":"Blood sampling will be made to Day 0, Day 3 and to 3 month after inclusion","armGroupLabels":["Case","Control"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Biomarker rates at day 0","description":"Biomarker: Neutro-Plaket aggregates, extra-cellular DNA networks, von Willebrand Factor","timeFrame":"24 hours"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Admitted to the Rothschild Foundation within the first 24 hours of an acute neurological symptomatology related to :\n* ischemic stroke eligible for a mechanical thrombectomy procedure\n* subarachnoid haemorrhage due to aneurysmal rupture: patient with at least a modified Fisher scale 3 or 4 (Appendix 4) and a World Federation of Neurological Surgeons (WFNS) score of 2 or more\n* intra-parenchymal haematoma with a Glasgow Coma Scale (GCS) strictly below 15.\n* tissue-based transient ischaemic attack - no lesion found on imaging - with ABCD2≥ 2 (control group).\n* Hospitalisation to the Fondation Adolphe de Rothschild Hospital at least 72 hours is planned\n\nExclusion Criteria:\n\n* Pre-existing functional and/or cognitive disability\n* Patient under legal protection\n* Pregnant or breastfeeding woman","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Patients treated at the Rothschild Foundation Hospital within the first 24 hours of an acute neurological symptomatology","samplingMethod":"PROBABILITY_SAMPLE"},"contactsLocationsModule":{"centralContacts":[{"name":"François DELVOYE","role":"CONTACT","phone":"0148036556","email":"fdelvoye@for.paris"},{"name":"Amélie Yavchitz","role":"CONTACT","phone":"0148036556","email":"fyavchitz@for.paris"}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000002534","term":"Hypoxia, Brain"},{"id":"D000007249","term":"Inflammation"},{"id":"D000000860","term":"Hypoxia"}],"ancestors":[{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000020521","term":"Stroke"},{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000012818","term":"Signs and Symptoms, Respiratory"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M3875","name":"Hypoxia","asFound":"Hypoxia","relevance":"HIGH"},{"id":"M9983","name":"Inflammation","asFound":"Inflammation","relevance":"HIGH"},{"id":"M5473","name":"Hypoxia, Brain","asFound":"Cerebral Hypoxia","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M15313","name":"Signs and Symptoms, Respiratory","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}